Free Trial

Achieve Life Sciences (ACHV) News Today

Achieve Life Sciences logo
$3.04 +0.07 (+2.36%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$3.18 +0.14 (+4.61%)
As of 05/23/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ACHV Latest News

Achieve Life Sciences, Inc. stock logo
Shay Capital LLC Sells 425,000 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV)
Shay Capital LLC trimmed its stake in Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) by 94.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 25,000 shares of the biopharmaceutical company's stock after selling 425,0
Q3 Earnings Forecast for ACHV Issued By Zacks Small Cap
Q2 Earnings Estimate for ACHV Issued By Zacks Small Cap
ACHV: Kicking Butts to Achieve June NDA Filing
Achieve Life Sciences, Inc. stock logo
Raymond James Financial Inc. Takes $554,000 Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV)
Raymond James Financial Inc. bought a new position in shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 157,519 shares of the biopharmaceutical company's stock, valued at app
Achieve Life Sciences, Inc. stock logo
Achieve Life Sciences (ACHV) Expected to Announce Quarterly Earnings on Thursday
Achieve Life Sciences (NASDAQ:ACHV) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-achieve-life-sciences-inc-stock/)
Achieve Life Sciences, Inc. stock logo
Raymond James Financial Inc. Invests $554,000 in Achieve Life Sciences, Inc. (NASDAQ:ACHV)
Raymond James Financial Inc. acquired a new stake in Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 157,519 shares of the biopharmaceutical company's stock, valued at approximately $554,
JonesTrading Keeps Their Buy Rating on Achieve Life Sciences (ACHV)
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory
Achieve Life Sciences, Inc. stock logo
Insider Buying: Achieve Life Sciences, Inc. (NASDAQ:ACHV) CFO Purchases 10,000 Shares of Stock
Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) CFO Mark K. Oki acquired 10,000 shares of the company's stock in a transaction dated Monday, March 17th. The shares were purchased at an average cost of $2.89 per share, for a total transaction of $28,900.00. Following the purchase, the chief financial officer now directly owns 10,000 shares in the company, valued at approximately $28,900. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
ACHV: 2Q:25 NDA Submission
Achieve Life Sciences, Inc. stock logo
Achieve Life Sciences (NASDAQ:ACHV) Announces Earnings Results
Achieve Life Sciences (NASDAQ:ACHV - Get Free Report) announced its earnings results on Tuesday. The biopharmaceutical company reported ($0.36) earnings per share for the quarter, missing analysts' consensus estimates of ($0.30) by ($0.06).
Lake Street Keeps Their Buy Rating on Achieve Life Sciences (ACHV)
Achieve Life Sciences, Inc. stock logo
Achieve Life Sciences (ACHV) Projected to Post Earnings on Tuesday
Achieve Life Sciences (NASDAQ:ACHV) will be releasing earnings before the market opens on Tuesday, March 11, Financial Modeling Prep reports.
Achieve Life Sciences, Inc. stock logo
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Short Interest Update
Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) was the target of a large decline in short interest in January. As of January 31st, there was short interest totalling 2,900,000 shares, a decline of 24.7% from the January 15th total of 3,850,000 shares. Based on an average daily trading volume, of 219,900 shares, the days-to-cover ratio is presently 13.2 days.
Achieve Life Sciences (ACHV) Gets a Buy from Lake Street
Achieve Life Sciences, Inc. stock logo
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Short Interest Up 30.0% in January
Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 3,810,000 shares, a growth of 30.0% from the December 31st total of 2,930,000 shares. Based on an average daily volume of 153,600 shares, the short-interest ratio is currently 24.8 days.
Achieve Life Sciences, Inc. stock logo
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Recommendation of "Buy" by Analysts
Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) has been given a consensus recommendation of "Buy" by the six ratings firms that are covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory
Achieve Life Sciences, Inc. stock logo
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Short Interest Up 30.0% in December
Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 3,810,000 shares, a growth of 30.0% from the December 15th total of 2,930,000 shares. Based on an average daily volume of 153,600 shares, the short-interest ratio is currently 24.8 days.
Achieve Life Sciences appoints Slaoui, Phelan to board of directors
Oppenheimer Sticks to Its Buy Rating for Achieve Life Sciences (ACHV)
Get Achieve Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter.

ACHV Media Mentions By Week

ACHV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACHV
News Sentiment

0.80

0.75

Average
Medical
News Sentiment

ACHV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACHV Articles
This Week

3

2

ACHV Articles
Average Week

Get Achieve Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ACHV) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners